• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON RESEARCH, LLC - HUNTINGTON ACRYSOF IQ VIVITY EXTENDED VISION IOL; INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON RESEARCH, LLC - HUNTINGTON ACRYSOF IQ VIVITY EXTENDED VISION IOL; INTRAOCULAR LENS Back to Search Results
Model Number DFT015
Medical Device Problem Codes Defective Component (2292); Device Dislodged or Dislocated (2923)
Health Effect - Clinical Code Visual Disturbances (2140)
Type of Reportable Event Serious Injury
Event or Problem Description
A non health care professional reported following implantation of intraocular lens (iol), the patient experienced cloudy vision.The lens was explanted in a secondary procedure.Additional information has been received and there was a quality issue with the lens that caused or contributed to the event indicating lens not centered, possible damage to haptic.The lens was exchanged with another lens model.
 
Additional Manufacturer Narrative
A sample device was not returned for analysis.Complaint history and product history records were reviewed and documentation indicated the product met release criteria.Root cause has not been identified.There have been no other complaints reported in the lot number.The manufacturer internal reference number is: (b)(4).
 
Event or Problem Description
Patient¿s issues have been resolved.Doctor¿s prognosis was indicated as good.
 
Additional Manufacturer Narrative
Patient's issues have resolved and the surgeon's prognosis is good.The manufacturer internal reference number is: (b)(4).
 
Additional Manufacturer Narrative
Correction g.3: supplemental medical device report (smdr) # 02 is being filed to correct the g.3 date on the supplemental report, filed earlier.Incorrect date of 22-sep-2022 is being corrected to 11-nov-2022.The manufacturer internal reference number is: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACRYSOF IQ VIVITY EXTENDED VISION IOL
Common Device Name
INTRAOCULAR LENS
Manufacturer (Section D)
ALCON RESEARCH, LLC - HUNTINGTON
6065 kyle lane
huntington WV 25702
Manufacturer (Section G)
ALCON RESEARCH, LLC - HUNTINGTON
6065 kyle lane
huntington WV 25702
Manufacturer Contact
jonathan schlech
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
8007579780
MDR Report Key15632302
Report Number1119421-2022-02225
Device Sequence Number12771316
Product Code POE
UDI-Device Identifier00380652421157
UDI-Public00380652421157
Combination Product (Y/N)N
Initial Reporter StateFL
Initial Reporter CountryUS
PMA/510(K) Number
P930014
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2022
Device Explanted Year2022
Reporter Type Manufacturer
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup,Followup
Report Date (Section B) 01/10/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date02/16/2025
Device Model NumberDFT015
Device Lot Number15038942
Was Device Available for Evaluation? No
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 09/22/2022
Supplement Date Received by Manufacturer09/22/2022
01/09/2023
Initial Report FDA Received Date10/19/2022
Supplement Report FDA Received Date12/07/2022
01/10/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured02/18/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
DUOVISC; MONARCH III CARTRIDGE D; MONARCH III IOL INJECTOR
Outcome Attributed to Adverse Event Required Intervention;
Patient Age76 YR
Patient SexMale
-
-